MYNVAX
Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. In addition, the technology allows for very rapid, large-scale, and low-cost production of vaccines that could potentially be used to protect people when there is a pandemic. Mynvax, which was incubated at the Indian Institute of Science, was founded in 2017 by Raghavan Varadarajan and Gautham Nadig.
MYNVAX
Social Links:
Industry:
Biotechnology Health Care
Founded:
2017-05-05
Address:
Bangalore, Karnataka, India
Country:
India
Website Url:
http://www.mynvax.com
Total Employee:
1+
Status:
Active
Total Funding:
4.13 M USD
Similar Organizations
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Current Employees Featured
Founder
Investors List
Accel
Accel investment in Series A - Mynvax
Kotak Investment Advisors
Kotak Investment Advisors investment in Series A - Mynvax
1Crowd
1Crowd investment in Series A - Mynvax
LetsVenture
LetsVenture investment in Series A - Mynvax
Ajith Sukumaran
Ajith Sukumaran investment in Angel Round - Mynvax
Official Site Inspections
http://www.mynvax.com
- Host name: 106.51.79.41.actcorp.in
- IP address: 106.51.79.41
- Location: Bengaluru India
- Latitude: 12.9721
- Longitude: 77.5933
- Timezone: Asia/Kolkata
- Postal: 560002

More informations about "Mynvax"
Mynvax
Mynvax, a clinical stage vaccine biotechnology company, was founded with the singular vision of developing novel, improved, recombinant, thermostable vaccines to protect against respiratory โฆ See details»
Mynvax - Crunchbase Company Profile & Funding
Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. See details»
Mynvax Company Profile - Office Locations, Competitors, Revenue โฆ
Mynvax has 5 employees at their 1 location and $4.2 m in total funding,. See insights on Mynvax including office locations, competitors, revenue, financials, executives, subsidiaries and more โฆ See details»
Mynvax - A Funded Healthtech Startup Based Out Of Bengaluru
Mynvax is a company based in Bengaluru, Karnataka, India, operating in the healthtech sector. Founded in 2017, it now employs 27 individuals. The company was established by Gautam โฆ See details»
Mynvax Company Profile Funding & Investors | YourStory
Efficacious vaccine for respiratory viruses.Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. In addition, the technology allows for very โฆ See details»
MYNVAX PRIVATE LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for MYNVAX PRIVATE LIMITED of Bengaluru, Karnataka. Get the latest business insights from Dun & โฆ See details»
Mynvax: About Us
Mynvax has developed multiple collaborations in India and overseas, with leading researchers in vaccine design, formulation expertise and clinical development. As a biotech start-up โฆ See details»
Mynvax - Accel
Mynvax led by Gautam Nadig and Raghavan Varadarajan has secured investment from Accel. Learn more. โ See details»
Mynvax - Funding, Financials, Valuation & Investors - Crunchbase
Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. See details»
Current Opportunities - Mynvax
Mynvax Private Limited, a clinical stage vaccine biotechnology company is seeking applications for a Research Associate in process development to support its R&D and commercialization โฆ See details»
Mynvax: Vaccine Design Workflow
Mynvax is currently working on two major vaccine programs: A multivalent vaccine against the human influenza virus. A broadly protective vaccine effective against SARS-CoV-2 and its โฆ See details»
Mynvax: Career Opportunities
Mynvax is an equal-opportunity employer, and we celebrate the diversity of our teams across levels. We are committed to creating an environment where every person working with us โฆ See details»
Mynvax: About Us
Gautham Nadig is co-founder and Executive Director of Mynvax Private Limited. Prior to co-founding Mynvax, Dr. Nadig was co-founder and Executive Director of Metahelix Life โฆ See details»
Add a new organization to ROR: Mynvax Private Limited #2788
Summary of request: Add a new organization to ROR Name of organization: Mynvax Website: www.mynvax.com Link to publications: 10.1021/acs.jpcb.2c07262, 10.3390/v15020346 โฆ See details»
Our investment in Mynvax - Accel
Mynvax, a biotech startup incubated at the Indian Institute of Science, Bangalore, has developed a recombinant vaccine platform that could revolutionize the domestic healthcare sector. The โฆ See details»
Mynvax - Contacts, Employees, Board Members, Advisors
Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. See details»
mynvax | PDF | Vaccines | Biology
Mynvax Private Limited is offering a 2-year industrial post-doctoral research fellowship focused on developing recombinant vaccines for influenza and SARS-CoV-2, with a salary of Rs. 75,000 โฆ See details»
Mynvax - 2025 Company Profile - Tracxn
Jun 14, 2025 Mynvax - Developer of novel recombinant vaccines to fight the human influenza virus and COVID19. Raised a total funding of $9.82M over 5 rounds from 76 investors. See details»
Mynvax Research Login
Mynvax Research Login Enter your email to get startedEmail See details»
National vaccine registry needed amid measles resurgence, โฆ
1 hour ago As Dr. Theresa Tam retires from her role as Canadaโs chief public health officer, she says thereโs an urgent need for a national vaccine registry to help prevent and manage crises โฆ See details»